×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 1: FDA Update and Potpourri
Session Chair(s)
J. Lynn Bass, PharmD, RPh
Senior Director, Medical Science Liaisons
BridgeBio, United States
Learning Objective : At the conclusion of this session, participants should be able to:- Identify the trends reflected in the latest enforcement actions and policies issued by the FDA
- Discuss how new FDA guidances will affect the roles of medical communications, medical science liaisons, and medical writing staff
Speaker(s)
Speaker
Darshan Kulkarni, JD, PharmD, MS
The Kulkarni Law Firm, United States
Principal Attorney
Have an account?